Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06229275 · ClinicalTrials.gov registry record · NA

Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection

A NA study of Cervical Cancer Screening, sponsored by Morehouse School of Medicine.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06229275 is a NA study of Cervical Cancer Screening that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 200 participants, below the 298-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06229275, a NA study of Cervical Cancer Screening, is actively recruiting participants, sponsored by Morehouse School of Medicine.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).

Conditions Studied

Interventions

  • DEVICE Pap smear collection using the Personal Pap Smear (PPS) Device
  • DEVICE Active Comparator: Pap smear collection using the Rovers Cervex-Brush

Study Locations (1)

Georgia

  • Morehouse School of Medicine - Atlanta

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-07-25
Est. Completion 2026-03-30
Phase NA

Sponsor

Morehouse School of Medicine

13 total trials

What the Registry Record Tells You About NCT06229275

The ClinicalTrials.gov registry entry for NCT06229275 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 298-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (33% lower). The listed sponsor is Morehouse School of Medicine, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Pap smear collection using the Personal Pap Smear (PPS) Device is the first listed.

NCT06229275 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06229275 about?

NCT06229275 is a clinical study titled "Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection". This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).

What is the current status of trial NCT06229275?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-07-25. Estimated completion is 2026-03-30.

What conditions does trial NCT06229275 study?

This clinical trial studies the following conditions: Cervical Cancer Screening.

What interventions are being tested in trial NCT06229275?

The interventions under investigation include: Pap smear collection using the Personal Pap Smear (PPS) Device (DEVICE), Active Comparator: Pap smear collection using the Rovers Cervex-Brush (DEVICE).

Who is sponsoring clinical trial NCT06229275?

This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06229275 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.